The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Development And Pre-Clinical Evaluation Of A Silicone Dressing For Scar Remediation
Funder
National Health and Medical Research Council
Funding Amount
$163,577.00
Summary
This research is aimed at exploiting advanced polymers as a new therapy for patients with burn related scars, as well as people who are genetically predisposed to scarring due to abnormal healing. In order to progress to clinical trials, the technology needs to be tested on an animal scar model. Successful outcome of these tests will allow the industry partner, Tissue Therapies, to proceed with a clinical trial, paving the way to a therapeutic product available for scar treatment.
Critical Infection: Ecological Solutions To Antibiotic Resistance
Funder
National Health and Medical Research Council
Funding Amount
$561,362.00
Summary
The applicant will apply new types of microbial data and diagnostic tools to early interventions in the critically ill and directly test their impact on clinical outcomes. He will also introduce novel therapies to restore antibiotic susceptibility to enteric bacteria and examine the clinical and microbiological effects of antibiotic decontamination of the critically ill in newly funded project grants. Overlapping research themes all link directly to his clinical and professional roles.
Mechanism Of Flightless I Function In Burn Injury And Scar Formation
Funder
National Health and Medical Research Council
Funding Amount
$545,216.00
Summary
Extensive scarring is a major clinical problem often resulting from burn injuries. We have previously shown that the cytoskeletal protein, Flightless I (FliI), is an important regulator of wound repair. We now plan to investigate whether FliI is also be the mechanistic link between cytoskeletal remodelling and induction of TGF-betas post-wounding leading to scar formation.
Wounds, burns and scalds are frequent injuries which can lead to deformity, disfigurement and loss of movement. We have shown that the cytoskeletal protein, Flightless I (FliI), is an important regulator of wound repair. We plan to further investigate FliI in wound and burn injuries using new cell-specific transgenic animal models and to develop a new FliI-antibody based therapy to treat wound and burn injuries.
Effect Of Cross-linking Cytokines To Natural And Synthetic Matrices On Post-implantation Fibrosis In Animal Models
Funder
National Health and Medical Research Council
Funding Amount
$77,154.00
Summary
My research will focus on the development and in vivo testing of cytokine cross-linked surgical implant materials in selected mouse and rat models. We hypothesise that Follistatin bound to heparin sulphate cross-linked natural and synthetic matrix implants will suppress the formation of Extra cellular matrix around the implant during wound healing in a mouse surgical model.
Utility Of Direct Endocardial Visualisation To Characterise Scar Morphology And Ablation Lesion Formation
Funder
National Health and Medical Research Council
Funding Amount
$421,285.00
Summary
Endocardial visualisation is a new technique in which a catheter is used to look at the internal surface of the heart without the need for surgery. We will use the visualisation catheter to find a better way of placing small burns within the heart to stop atrial fibrillation (one of the most common heart diseases). We will also use the visualisation catheter to find a better way of locating the scarred areas of the heart responsible for ventricular tachycardia (another common heart disease).
Wounds are not just the simple cuts and abrasions that can be covered with a band-aid and healed within days with no major consequence. They are a largely unrecognised spiralling epidemic that is affecting millions of people world-wide. This project aims to develop new approaches to heal wounds with research that is innovative, cross-disciplinary and has the ability to transform current approaches for wound management.
Development Of Flightless Antibody Therapy For Treating Wounds
Funder
National Health and Medical Research Council
Funding Amount
$194,071.00
Summary
Chronic wounds, diabetic ulcers, injuries in response to trauma, burns and scalds form a medical need which will only expand as the population ages and the diabetic epidemic grows. In our studies, we have shown that Flightless I (FliI), an actin-remodelling protein, is a negative regulator of incisional wound healing. We are now developing a new antibody therapy to reduce FliI levels in wounds thereby leading to improved wound repair outcomes.